RHYNOSTAT H-12 & V-22— 510(k) K852349

Name: FDA 510(k) clearance K852349
Creator: U.S. Food and Drug Administration
Published: 1985-09-03

Substantially Equivalent

Remesta Medical Corp.

FDA 510(k) clearance K852349 for RHYNOSTAT H-12 & V-22, Substantially Equivalent on 1985-09-03. Applicant: Remesta Medical Corp.. Device class: 2.

Clearance details

Applicant: Remesta Medical Corp.
Product code: Code KPR
Device class: Class 2
Regulation: 21 CFR 892.1680
Advisory panel: Radiology
Date received: 1985-05-31
Decision date: 1985-09-03
Decision: Substantially Equivalent
Clearance type: Traditional
Location: New Hyde Park, NY, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code KPR

view all

K260227 — EXSYS DEXi (EXSYS DEXi-S40S); EXSYS DEXi (EXSYS DEXi-S40P); EXSYS DEXi (EXSYS DEXi-S40T); EXSYS DEXi (EXSYS DEXi-S50H2026-09-08
K260488 — MULTIX Impact; MULTIX Impact C2026-08-31
K260481 — GC85A2026-08-27
K260482 — DRE Duo2026-06-15
K253446 — AeroDR TX c022026-04-10

Adverse events under product code KPR

product code KPR

Other: 6
Total: 6

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.